Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cortisone is a synthetic corticosteroid hormone (glucocorticoid) used to treat a wide range of inflammatory, autoimmune, and hormonal conditions. It works by suppressing the immune response and reducing inflammation throughout the body. Cortisone itself is inactive and must be converted in the liver to its active form, cortisol, via 11β-hydroxysteroid dehydrogenase type 1. Its primary mechanisms include binding to glucocorticoid receptors to inhibit pro-inflammatory signals and promote anti-inflammatory gene expression. Indications for cortisone include rheumatoid arthritis, various allergic reactions, skin disorders (such as eczema), endocrine disorders like Addison’s disease (as hormone replacement), respiratory diseases such as asthma, certain cancers for symptom relief, and other conditions responsive to corticosteroids[2][7][8][9]. It can be administered orally or by injection.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on cortisone.